Home
Conditions
Skin Neoplasms

Clinical trial condition

Skin Neoplasms

Explore clinical trials studying Skin Neoplasms. Study availability and eligibility vary by location and protocol.

2,111 public trials 360 recruiting studies

Refine in advanced search Browse all conditions

Skin Neoplasms trial results

Completed

Study of NY-ESO-1 ISCOMATRIX® in Patients With Measurable Stage III or IV Melanoma

NCT00518206

Conditions: Melanoma, Neoplasms, Neoplasms by Histologic Type, +9 more
Locations: Peter MacCallum Cancer Institute East Melbourne, Victoria, Australia

Austin Health (Ludwig Institute Oncology Unit) Heidelberg, Victoria, Australia

View Trial Details

Completed

Optical Biopsy of Human Skin in Conjunction With Laser Treatment

NCT00540566

Conditions: Adenocarcinoma, Atypical Nevi, Basal Cell Carcinoma, +64 more
Locations: Beckman Laser Institute, Unversity of California Irvine Irvine, California, United States

View Trial Details

Completed

Prostaglandin Inhibition and Immune Checkpoint Blockade in Melanoma

NCT03396952

Conditions: Melanoma, Neoplasms, Neoplasms by Histologic Type, +14 more
Locations: University of Califonia, San Francisco San Francisco, California, United States

View Trial Details

Completed

Study of NY-ESO-1 ISCOMATRIX® in Patients With High-risk, Resected Melanoma

NCT00199901

Conditions: Melanoma, Neoplasms, Neoplasms by Histologic Type, +9 more
Locations: Sydney Melanoma Unit - Royal Prince Alfred Hospital Camperdown, New South Wales, Australia

Newcastle Melanoma Unit - Newcastle Mater Misericordiae Hospital Newcastle, New South Wales, Australia

Mater Medical Centre, Princess Alexandra Hospital Woolloongabba, Queensland, Australia

Peter MacCallum Cancer Centre East Melbourne, Victoria, Australia

View all 15 locations

View Trial Details

Completed

Safety and Efficacy of AK104, a PD-1/CTLA-4 Bispecific Antibody, in Selected Advanced Solid Tumors

NCT04172454

Conditions: Advanced Solid Tumors, Melanoma, Neoplasms, +10 more
Locations: Sun Yat-Sen University Cancer Center Guangzhou, Guangdong, China

View Trial Details

Completed

Phase II Study of KW2871 Combined With High Dose Interferon-α2b in Patients With Metastatic Melanoma

NCT00679289

Conditions: Cutaneous Melanoma, Melanoma, Metastatic Melanoma, +11 more
Locations: University of Chicago Hospital Chicago, Illinois, United States

University of Pittsburgh Cancer Institute Pittsburgh, Pennsylvania, United States

View Trial Details

Completed

NY-ESO-1 Protein Vaccine With Imiquimod in Melanoma (Adjuvant Setting)

NCT00142454

Conditions: Malignant Melanoma, Melanoma, Neoplasms, +10 more
Locations: NYU Cancer Institute New York, United States

View Trial Details

Completed

Avadomide (CC-122) in Combination With Nivolumab in Advanced Melanoma

NCT03834623

Conditions: Melanoma, Neoplasms, Neoplasms by Histologic Type, +9 more
Locations: H Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States

View Trial Details

Completed

A Study of RO7293583 in Participants With Unresectable Metastatic Tyrosinase Related Protein 1 (TYRP1)-Positive Melanomas

NCT04551352

Conditions: Cutaneous Melanoma, Eye Diseases, Eye Neoplasms, +16 more
Locations: Dana Farber Cancer Institute Boston, Massachusetts, United States

Memorial Sloan-Kettering Cancer Center New York, United States

Thomas Jefferson University Hospital;Medical Oncology Philadelphia, Pennsylvania, United States

Sarah Cannon Research Institute Nashville, Tennessee, United States

View all 14 locations

View Trial Details

Completed

Modifying Young Adult Skin Cancer Risk and Protective Behaviors

NCT03313492

Conditions: Melanoma, Melanoma and Other Malignant Neoplasms of Skin, Neoplasms, +10 more
Locations: Rutgers Cancer Institute of New Jersey New Brunswick, New Jersey, United States

Fox Chase Cancer Center Philadelphia, Pennsylvania, United States

View Trial Details

Skin Neoplasms

Skin Neoplasms trial results

Related conditions